Filing Details
- Accession Number:
- 0000950170-25-038750
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-13 16:13:26
- Reporting Period:
- 2025-03-13
- Filing Date:
- 2025-03-13
- Accepted Time:
- 2025-03-13 16:13:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818794 | Dyne Therapeutics Inc. | DYN | Pharmaceutical Preparations (2834) | 364883909 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1915598 | Johanna Friedl-Naderer | C/O Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham MA 02451 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-03-13 | 143 | $12.12 | 96,057 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.
- Includes 93,838 unvested RSUs.
Billionaire Hedge Funds
